LEADER 03602nam  22006014a 450 
001 9910830148103321
005 20230617020259.0
010   $a1-280-27119-1
010   $a9786610271191
010   $a0-470-86119-3
010   $a0-470-86115-0
035   $a(CKB)111090529061268
035   $a(EBL)189682
035   $a(SSID)ssj0000103158
035   $a(PQKBManifestationID)11113643
035   $a(PQKBTitleCode)TC0000103158
035   $a(PQKBWorkID)10061099
035   $a(PQKB)10706289
035   $a(MiAaPQ)EBC189682
035   $a(OCoLC)85820770
035   $a(EXLCZ)99111090529061268
100   $a20040825d2004      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAnaphylaxis$b[electronic resource]
210   $aChichester ;$aHoboken, NJ $cJohn Wiley & Sons$d2004
215   $a1 online resource (308 p.)
225 1 $aNovartis Foundation symposium ;$v257
300   $a"Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode."--Contents p.
311   $a0-470-86114-2 
320   $aIncludes bibliographical references and indexes.
327   $aANAPHYLAXIS; Contents; Participants; Chair's introduction; History and classification of anaphylaxis; Discussion; Rethinking Th2 antibody responses and allergic sensitization; Discussion; General discussion I; The high affinity receptor for IgE, FceRI; Discussion; Effector cells of anaphylaxis: mast cells and basophils; Discussion; Cytokine enhancement of anaphylaxis; Discussion; General discussion II; Patterns of anaphylaxis: acute and late phase features of allergic reactions; Discussion; Fatal anaphylaxis in the UK, 1992-2001; Discussion; The human heart as a shock organ in anaphylaxis
327   $aDiscussion General discussion III; Food-induced anaphylaxis; Discussion; Anaphylaxis to insect venom; Discussion; Anaphylaxis to anaesthetic drugs; Discussion; General discussion IV; The radiocontrast molecule in anaphylaxis. A surprising antigen; Discussion; General discussion V Fatal course of Vespula venom immunotherapy: pretreatment withdrawal of the b blocker may have been involved; Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis; Discussion; New approaches for the treatment of anaphylaxis; Discussion
327   $aPatient's perspective and public policy regarding anaphylaxis Discussion; Final discussion; Index of contributors; Subject index
330   $aAnaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals.Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated
410  0$aNovartis Foundation symposium ;$v257.
606   $aAnaphylaxis$vCongresses
615  0$aAnaphylaxis
676   $a614.5/993
676   $a616.97
701   $aBock$b Gregory$0322650
701   $aGoode$b Jamie$0283336
712 02$aNovartis Foundation.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830148103321
996   $aAnaphylaxis$93984818
997   $aUNINA